{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T02:57:38Z","timestamp":1781665058454,"version":"3.54.5"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-025-06765-1","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T21:09:41Z","timestamp":1739308181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of a multi-action tear substitute based on 0.15% cross-linked hyaluronic acid, 3% trehalose and liposomes with stearylamine: A randomized, single-mask, controlled study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9248-8685","authenticated-orcid":false,"given":"Antonio","family":"Ballesteros-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Roberto","family":"Tedesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rocha-de-Lossada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedele","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Mar\u00eda","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"6765_CR1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/J.JTOS.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY et al (2017) TFOS DEWS II epidemiology report. Ocul Surf 15:334\u2013365. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.003","journal-title":"Ocul Surf"},{"key":"6765_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/J.JTOS.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK et al (2017) TFOS DEWS II definition and classification report. Ocul Surf 15:276\u2013283. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.008","journal-title":"Ocul Surf"},{"key":"6765_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/J.JTOS.2017.05.011","volume":"15","author":"AJ Bron","year":"2017","unstructured":"Bron AJ, de Paiva CS, Chauhan SK et al (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438\u2013510. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.011","journal-title":"Ocul Surf"},{"key":"6765_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/J.JTOS.2016.04.005","volume":"14","author":"S Barabino","year":"2016","unstructured":"Barabino S, Labetoulle M, Rolando M, Messmer EM (2016) Understanding symptoms and quality of life in patients with Dry Eye Syndrome. Ocul Surf 14:365\u2013376. https:\/\/doi.org\/10.1016\/J.JTOS.2016.04.005","journal-title":"Ocul Surf"},{"key":"6765_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jtos.2018.11.003","volume":"17","author":"JAP Gomes","year":"2019","unstructured":"Gomes JAP, Santo RM (2019) The impact of dry eye disease treatment on patient satisfaction and quality of life: a review. Ocul Surf 17:9\u201319. https:\/\/doi.org\/10.1016\/j.jtos.2018.11.003","journal-title":"Ocul Surf"},{"key":"6765_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","volume":"15","author":"JS Wolffsohn","year":"2017","unstructured":"Wolffsohn JS, Arita R, Chalmers R et al (2017) TFOS DEWS II diagnostic methodology report. Ocul Surf 15:539\u2013574. https:\/\/doi.org\/10.1016\/j.jtos.2017.05.001","journal-title":"Ocul Surf"},{"key":"6765_CR7","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","volume":"23","author":"KK Nichols","year":"2004","unstructured":"Nichols KK, Nichols JJ, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23:762\u2013770. https:\/\/doi.org\/10.1097\/01.ico.0000133997.07144.9e","journal-title":"Cornea"},{"key":"6765_CR8","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/eye.2010.228","volume":"25","author":"H Pult","year":"2011","unstructured":"Pult H, Purslow C, Murphy PJ (2011) The relationship between clinical signs and dry eye symptoms. Eye (Lond) 25:502\u2013510. https:\/\/doi.org\/10.1038\/eye.2010.228","journal-title":"Eye (Lond)"},{"key":"6765_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/J.JTOS.2017.03.006","volume":"15","author":"MDP Willcox","year":"2017","unstructured":"Willcox MDP, Arg\u00fceso P, Georgiev GA et al (2017) TFOS DEWS II tear film report. Ocul Surf 15:366\u2013403. https:\/\/doi.org\/10.1016\/J.JTOS.2017.03.006","journal-title":"Ocul Surf"},{"key":"6765_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/J.JTOS.2017.05.006","volume":"15","author":"L Jones","year":"2017","unstructured":"Jones L, Downie LE, Korb D et al (2017) TFOS DEWS II management and therapy report. Ocul Surf 15:575\u2013628. https:\/\/doi.org\/10.1016\/J.JTOS.2017.05.006","journal-title":"Ocul Surf"},{"key":"6765_CR11","doi-asserted-by":"publisher","first-page":"8642","DOI":"10.26355\/EURREV_202009_22801","volume":"24","author":"S Barabino","year":"2020","unstructured":"Barabino S, Benitez-Del-Castillo JM, Fuchsluger T et al (2020) Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification. Eur Rev Med Pharmacol Sci 24:8642\u20138652. https:\/\/doi.org\/10.26355\/EURREV_202009_22801","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6765_CR12","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/S40123-022-00518-7","volume":"11","author":"L Vigo","year":"2022","unstructured":"Vigo L, Senni C, Pellegrini M et al (2022) Effects of a new formulation of multiple-action tear substitute on objective ocular surface parameters and ocular discomfort symptoms in patients with dry eye disease. Ophthalmol Ther 11:1441. https:\/\/doi.org\/10.1007\/S40123-022-00518-7","journal-title":"Ophthalmol Ther"},{"issue":"23","key":"6765_CR13","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.3390\/JCM11236975","volume":"11","author":"AM Roszkowska","year":"2022","unstructured":"Roszkowska AM, Inferrera L, Spinella R et al (2022) Clinical efficacy, tolerability and safety of a new multiple-action eyedrop in subjects with moderate to severe dry eye. J Clin Med 11(23):6975. https:\/\/doi.org\/10.3390\/JCM11236975","journal-title":"J Clin Med"},{"key":"6765_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.2478\/ACPH-2019-0054","volume":"69","author":"BJ Dukovski","year":"2019","unstructured":"Dukovski BJ, Bra\u010dko A, \u0160are M et al (2019) In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery. Acta Pharm 69:621\u2013634. https:\/\/doi.org\/10.2478\/ACPH-2019-0054","journal-title":"Acta Pharm"},{"key":"6765_CR15","unstructured":"Angelinetta C, Pastoris O, Pianca U, Regola E, Vicini R (2020) In vitro evaluation of the protective action of a product against IV rays on reconstructed human ocular epithelium. Data on file, protocol n. 2002128V2-1. Bio Basic Europe Srl"},{"key":"6765_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1089\/JOP.2018.0151","volume":"35","author":"C Posarelli","year":"2019","unstructured":"Posarelli C, Passani A, Del Re M et al (2019) Cross-linked hyaluronic acid as tear film substitute. J Ocul Pharmacol Ther 35:381\u2013387. https:\/\/doi.org\/10.1089\/JOP.2018.0151","journal-title":"J Ocul Pharmacol Ther"},{"key":"6765_CR17","doi-asserted-by":"publisher","unstructured":"Laihia J, Kaarniranta K (2020) Trehalose for ocular surface health.\u00a0Biomolecules 10:.\u00a0https:\/\/doi.org\/10.3390\/BIOM10050809","DOI":"10.3390\/BIOM10050809"},{"key":"6765_CR18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/J.CLAE.2019.10.001","volume":"43","author":"EE Karaca","year":"2020","unstructured":"Karaca EE, \u00d6zek D, Evren Kemer \u00d6 (2020) Comparison study of two different topical lubricants on tear meniscus and tear osmolarity in dry eye. Cont Lens Anterior Eye 43:373\u2013377. https:\/\/doi.org\/10.1016\/J.CLAE.2019.10.001","journal-title":"Cont Lens Anterior Eye"},{"key":"6765_CR19","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/AOS.15159","volume":"100","author":"L Hynnekleiv","year":"2022","unstructured":"Hynnekleiv L, Magno M, Vernhardsdottir RR et al (2022) Hyaluronic acid in the treatment of dry eye disease. Acta Ophthalmol 100:844\u2013860. https:\/\/doi.org\/10.1111\/AOS.15159","journal-title":"Acta Ophthalmol"},{"key":"6765_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/S43441-019-00073-7","volume":"54","author":"JB Christian","year":"2020","unstructured":"Christian JB, Brouwer ES, Girman CJ et al (2020) Masking in pragmatic trials: who, what, and when to Blind. Ther Innov Regul Sci 54:431\u2013436. https:\/\/doi.org\/10.1007\/S43441-019-00073-7","journal-title":"Ther Innov Regul Sci"},{"key":"6765_CR21","doi-asserted-by":"publisher","unstructured":"Ballesteros-S\u00e1nchez A, Gargallo-Mart\u00ednez B, Guti\u00e9rrez-Ortega R, S\u00e1nchez-Gonz\u00e1lez J-M (2023) Intra-observer repeatability assessment of the S390L Firefly WDR slit lamp in patients with dry eye disease: Objective, automated and non-invasive measures. Eye Contact Lens 49(7):283\u2013291.\u00a0https:\/\/doi.org\/10.1097\/ICL.0000000000001001","DOI":"10.1097\/ICL.0000000000001001"},{"key":"6765_CR22","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.1167\/IOVS.11-8027","volume":"52","author":"BE Dougherty","year":"2011","unstructured":"Dougherty BE, Nichols JJ, Nichols KK (2011) Rasch analysis of the ocular surface disease index (OSDI). Invest Ophthalmol Vis Sci 52:8630\u20138635. https:\/\/doi.org\/10.1167\/IOVS.11-8027","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6765_CR23","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/ARCHOPHT.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G et al (2000) Reliability and validity of the ocular surface disease index. Arch Ophthalmol 118:615\u2013621. https:\/\/doi.org\/10.1001\/ARCHOPHT.118.5.615","journal-title":"Arch Ophthalmol"},{"key":"6765_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/1740774515602688","volume":"13","author":"JM Lachin","year":"2016","unstructured":"Lachin JM (2016) Fallacies of last observation carried forward analyses. Clin Trials 13:161\u2013168. https:\/\/doi.org\/10.1177\/1740774515602688","journal-title":"Clin Trials"},{"key":"6765_CR25","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/ICL.0B013E3182658699","volume":"38","author":"M Guillon","year":"2012","unstructured":"Guillon M, Maissa C, Wong S (2012) Symptomatic relief associated with eyelid hygiene in anterior blepharitis and MGD. Eye Contact Lens 38:306\u2013312. https:\/\/doi.org\/10.1097\/ICL.0B013E3182658699","journal-title":"Eye Contact Lens"},{"key":"6765_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1080\/02713683.2019.1686153","volume":"45","author":"O Murphy","year":"2020","unstructured":"Murphy O, O\u2019 Dwyer V, Lloyd-Mckernan A (2020) The efficacy of warm compresses in the treatment of meibomian gland dysfunction and demodex folliculorum blepharitis. Curr Eye Res 45:563\u2013575. https:\/\/doi.org\/10.1080\/02713683.2019.1686153","journal-title":"Curr Eye Res"},{"key":"6765_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/S00417-021-05363-1","volume":"260","author":"J Hu","year":"2022","unstructured":"Hu J, Zhu S, Liu X (2022) Efficacy and safety of a vectored thermal pulsation system (Lipiflow\u00ae) in the treatment of meibomian gland dysfunction: a systematic review and meta-analysis. Graefes Arch Clin Exp Ophthalmol 260:25\u201339. https:\/\/doi.org\/10.1007\/S00417-021-05363-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6765_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00417-020-04834-1","volume":"259","author":"X Leng","year":"2021","unstructured":"Leng X, Shi M, Liu X et al (2021) Intense pulsed light for meibomian gland dysfunction: a systematic review and meta-analysis. Graefe\u2019s Archive Clin Experimental Ophthalmol 259:1\u201310. https:\/\/doi.org\/10.1007\/s00417-020-04834-1","journal-title":"Graefe\u2019s Archive Clin Experimental Ophthalmol"},{"issue":"2","key":"6765_CR29","doi-asserted-by":"publisher","first-page":"102107","DOI":"10.1016\/J.CLAE.2023.102107","volume":"47","author":"A Ballesteros-S\u00e1nchez","year":"2024","unstructured":"Ballesteros-S\u00e1nchez A, S\u00e1nchez-Gonz\u00e1lez JM, Carmen S\u00e1nchez-Gonz\u00e1lez M et al (2024) Efficacy of meibomian gland expression combined with home-based therapy in the management of dry eye disease: A systematic review and meta-analysis. Cont Lens Anterior Eye 47(2):102107. https:\/\/doi.org\/10.1016\/J.CLAE.2023.102107","journal-title":"Cont Lens Anterior Eye"},{"issue":"5","key":"6765_CR30","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3390\/IJMS23052434","volume":"23","author":"M Labetoulle","year":"2022","unstructured":"Labetoulle M, Benitez-Del-castillo JM, Barabino S et al (2022) Artificial tears: Biological role of their ingredients in the management of dry eye disease. Int J Mol Sci 23(5):2434. https:\/\/doi.org\/10.3390\/IJMS23052434","journal-title":"Int J Mol Sci"},{"key":"6765_CR31","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/ICO.0000000000000575","volume":"34","author":"J Baek","year":"2015","unstructured":"Baek J, Doh SH, Chung SK (2015) Comparison of tear meniscus height measurements obtained with the keratograph and fourier domain optical coherence tomography in dry eye. Cornea 34:1209\u20131213. https:\/\/doi.org\/10.1097\/ICO.0000000000000575","journal-title":"Cornea"},{"key":"6765_CR32","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1167\/IOVS.18-24850","volume":"60","author":"R Arita","year":"2019","unstructured":"Arita R, Yabusaki K, Hirono T et al (2019) Automated measurement of tear meniscus height with the kowa DR-1\u03b1 tear interferometer in both healthy subjects and dry eye patients. Invest Ophthalmol Vis Sci 60:2092\u20132101. https:\/\/doi.org\/10.1167\/IOVS.18-24850","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6765_CR33","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/ARCHOPHTHALMOL.2009.356","volume":"128","author":"KL Miller","year":"2010","unstructured":"Miller KL, Walt JG, Mink DR et al (2010) Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 128:94\u2013101. https:\/\/doi.org\/10.1001\/ARCHOPHTHALMOL.2009.356","journal-title":"Arch Ophthalmol"},{"key":"6765_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJERPH18052383","volume":"18","author":"YJ Yang","year":"2021","unstructured":"Yang YJ, Lee WY, Kim YJ, Hong YP (2021) A meta-analysis of the efficacy of hyaluronic acid eye drops for the treatment of dry eye syndrome. Int J Environ Res Public Health 18:1\u201314. https:\/\/doi.org\/10.3390\/IJERPH18052383","journal-title":"Int J Environ Res Public Health"},{"key":"6765_CR35","doi-asserted-by":"publisher","unstructured":"Aragona P, Simmons PA, Wang H, Wang T (2019) Physicochemical properties of hyaluronic acid-based lubricant eye drops. Transl Vis Sci Technol 8(6). https:\/\/doi.org\/10.1167\/TVST.8.6.2","DOI":"10.1167\/TVST.8.6.2"},{"key":"6765_CR36","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1089\/JOP.2016.0149","volume":"33","author":"C Cagini","year":"2017","unstructured":"Cagini C, Torroni G, Fiore T et al (2017) Tear film stability in sj\u00f6gren syndrome patients treated with hyaluronic acid versus crosslinked hyaluronic acid-based eye drops. J Ocul Pharmacol Ther 33:539\u2013542. https:\/\/doi.org\/10.1089\/JOP.2016.0149","journal-title":"J Ocul Pharmacol Ther"},{"key":"6765_CR37","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1167\/IOVS.16-20848","volume":"58","author":"DL Williams","year":"2017","unstructured":"Williams DL, Wirostko BM, Gum G, Mann BK (2017) Topical cross-linked HA-based hydrogel accelerates closure of corneal epithelial defects and repair of stromal ulceration in companion animals. Invest Ophthalmol Vis Sci 58:4616\u20134622. https:\/\/doi.org\/10.1167\/IOVS.16-20848","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"6765_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/J.1463-5224.2010.00771.X","volume":"13","author":"G Yang","year":"2010","unstructured":"Yang G, Espandar L, Mamalis N, Prestwich GD (2010) A cross-linked hyaluronan gel accelerates healing of corneal epithelial abrasion and alkali burn injuries in rabbits. Vet Ophthalmol 13:144\u2013150. https:\/\/doi.org\/10.1111\/J.1463-5224.2010.00771.X","journal-title":"Vet Ophthalmol"},{"key":"6765_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.2147\/OPTH.S174290","volume":"12","author":"C Fariselli","year":"2018","unstructured":"Fariselli C, Giannaccare G, Fresina M, Versura P (2018) Trehalose\/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients. Clin Ophthalmol 12:1293\u20131300. https:\/\/doi.org\/10.2147\/OPTH.S174290","journal-title":"Clin Ophthalmol"},{"key":"6765_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2147\/OPTH.S18827","volume":"5","author":"J Luyckx","year":"2011","unstructured":"Luyckx J, Baudouin C (2011) Trehalose: an intriguing disaccharide with potential for medical application in ophthalmology. Clin Ophthalmol 5:577\u2013581. https:\/\/doi.org\/10.2147\/OPTH.S18827","journal-title":"Clin Ophthalmol"},{"key":"6765_CR41","doi-asserted-by":"publisher","first-page":"611","DOI":"10.14670\/HH-18-082","volume":"34","author":"C Cejka","year":"2019","unstructured":"Cejka C, Kubinova S, \u010cejkov\u00e1 J (2019) Trehalose in ophthalmology. Histol Histopathol 34:611\u2013618. https:\/\/doi.org\/10.14670\/HH-18-082","journal-title":"Histol Histopathol"},{"issue":"23","key":"6765_CR42","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.3390\/jcm12237301","volume":"12","author":"A Ballesteros-S\u00e1nchez","year":"2023","unstructured":"Ballesteros-S\u00e1nchez A, Martinez-Perez C, Alvarez-Peregrina C et al (2023) Trehalose and dry eye disease: A comprehensive systematic review of randomized controlled trials. J Clin Med 12(23):7301. https:\/\/doi.org\/10.3390\/jcm12237301","journal-title":"J Clin Med"},{"key":"6765_CR43","doi-asserted-by":"publisher","unstructured":"Vicario-de-la-Torre M, Caballo-Gonz\u00e1lez M, Vico E et al (2018) Novel nano-liposome formulation for dry eyes with components similar to the preocular tear film. Polymers (Basel) 10:. https:\/\/doi.org\/10.3390\/POLYM10040425","DOI":"10.3390\/POLYM10040425"},{"issue":"5","key":"6765_CR44","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/J.HELIYON.2022.E09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U et al (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8(5):e09394. https:\/\/doi.org\/10.1016\/J.HELIYON.2022.E09394","journal-title":"Heliyon"},{"key":"6765_CR45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1089\/JOP.2020.0011","volume":"36","author":"P Daull","year":"2020","unstructured":"Daull P, Amrane M, Ismail D et al (2020) Cationic emulsion-based artificial tears as a mimic of functional healthy tear film for restoration of ocular surface homeostasis in dry eye disease. J Ocul Pharmacol Ther 36:355\u2013365. https:\/\/doi.org\/10.1089\/JOP.2020.0011","journal-title":"J Ocul Pharmacol Ther"},{"key":"6765_CR46","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","volume":"40","author":"J Tauber","year":"2021","unstructured":"Tauber J, Wirta DL, Sall K et al (2021) A randomized clinical study (SEECASE) to assess efficacy, safety, and tolerability of NOV03 for treatment of dry eye disease. Cornea 40:1132\u20131140. https:\/\/doi.org\/10.1097\/ICO.0000000000002622","journal-title":"Cornea"},{"key":"6765_CR47","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5301\/EJO.5000830","volume":"26","author":"PY Robert","year":"2016","unstructured":"Robert PY, Cochener B, Amrane M et al (2016) Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study. Eur J Ophthalmol 26:546\u2013555. https:\/\/doi.org\/10.5301\/EJO.5000830","journal-title":"Eur J Ophthalmol"},{"key":"6765_CR48","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/JOP.2017.0052","volume":"33","author":"JS Garrigue","year":"2017","unstructured":"Garrigue JS, Amrane M, Faure MO et al (2017) Relevance of lipid-based products in the management of dry eye disease. J Ocul Pharmacol Ther 33:647. https:\/\/doi.org\/10.1089\/JOP.2017.0052","journal-title":"J Ocul Pharmacol Ther"},{"key":"6765_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OPTH.S1496","volume":"2","author":"G Savini","year":"2008","unstructured":"Savini G, Prabhawasat P, Kojima T et al (2008) The challenge of dry eye diagnosis. Clin Ophthalmol 2:31. https:\/\/doi.org\/10.2147\/OPTH.S1496","journal-title":"Clin Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-025-06765-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-025-06765-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:20:06Z","timestamp":1739463606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-025-06765-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":49,"alternative-id":["6765"],"URL":"https:\/\/doi.org\/10.1007\/s00417-025-06765-1","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"2 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was approved by the ethics committees of all participating centers (approval Nr. VR-73-2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All subjects from this research read, signed, and gave the researcher their informed consent prior to their inclusion in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}